Clinical comparison and genetic analysis in pheochromocytoma with primary aldosteronism

Pheochromocytoma is a rare form of adrenal hypertension. This study aimed to investigate the clinical characteristics and associated genetic mutations in patients with pheochromocytoma and primary aldosteronism. We retrospectively analyzed data from 23 patients with pheochromocytoma diagnosed and tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Xurong Mai, Mitsuhiro Kometani, Toshiaki Kato, Ko Aiga, Shigehiro Karashima, Daisuke Aono, Seigo Konishi, Koshiro Nishimoto, Kazuyoshi Hosomichi, Atsushi Watanabe, Yuko Noda, Yoshiyu Takeda, Takashi Yoneda
Format: Article
Language:English
Published: The Japan Endocrine Society 2025-02-01
Series:Endocrine Journal
Subjects:
Online Access:https://www.jstage.jst.go.jp/article/endocrj/72/2/72_EJ24-0150/_html/-char/en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565306423246848
author Xurong Mai
Mitsuhiro Kometani
Toshiaki Kato
Ko Aiga
Shigehiro Karashima
Daisuke Aono
Seigo Konishi
Koshiro Nishimoto
Kazuyoshi Hosomichi
Atsushi Watanabe
Yuko Noda
Yoshiyu Takeda
Takashi Yoneda
author_facet Xurong Mai
Mitsuhiro Kometani
Toshiaki Kato
Ko Aiga
Shigehiro Karashima
Daisuke Aono
Seigo Konishi
Koshiro Nishimoto
Kazuyoshi Hosomichi
Atsushi Watanabe
Yuko Noda
Yoshiyu Takeda
Takashi Yoneda
author_sort Xurong Mai
collection DOAJ
description Pheochromocytoma is a rare form of adrenal hypertension. This study aimed to investigate the clinical characteristics and associated genetic mutations in patients with pheochromocytoma and primary aldosteronism. We retrospectively analyzed data from 23 patients with pheochromocytoma diagnosed and treated between 2011 and 2022. Three cases were complicated by primary aldosteronism. Compared to 15 other patients without primary aldosteronism complications, these three patients had a greater suppression of plasma renin activity (0.2 vs. 2.3 ng/mL/h, p < 0.01) and a higher aldosterone-to-renin ratio (p < 0.01). No significant differences were found in blood pressure, serum potassium levels, or plasma aldosterone concentrations between the two groups. In genetic analysis, among the three patients with pheochromocytoma and primary aldosteronism, two had a KCNJ5 (G151R) mutation in the pheochromocytoma tumor tissues. However, no CYP11B2- or CYP11B1-positive cells were detected via immunostaining in the pheochromocytoma tissues of these three patients. To our knowledge, this is the first study to reveal the presence of the KCNJ5 mutation, commonly considered specific to primary aldosteronism, in pheochromocytoma cases clinically complicated by primary aldosteronism. The findings suggest that patients with pheochromocytoma and suppressed plasma renin activity should be assessed for primary aldosteronism.
format Article
id doaj-art-6a7d4719e85c498caacdf164cf7ea960
institution Kabale University
issn 1348-4540
language English
publishDate 2025-02-01
publisher The Japan Endocrine Society
record_format Article
series Endocrine Journal
spelling doaj-art-6a7d4719e85c498caacdf164cf7ea9602025-02-03T01:08:32ZengThe Japan Endocrine SocietyEndocrine Journal1348-45402025-02-0172219320310.1507/endocrj.EJ24-0150endocrjClinical comparison and genetic analysis in pheochromocytoma with primary aldosteronismXurong Mai0Mitsuhiro Kometani1Toshiaki Kato2Ko Aiga3Shigehiro Karashima4Daisuke Aono5Seigo Konishi6Koshiro Nishimoto7Kazuyoshi Hosomichi8Atsushi Watanabe9Yuko Noda10Yoshiyu Takeda11Takashi Yoneda12Department of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, JapanDepartment of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, JapanDepartment of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, JapanDepartment of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, JapanDepartment of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, JapanDepartment of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, JapanDepartment of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, JapanDepartment of Uro-Oncology, International Medical Center Saitama Medical University, Saitama 350-1298, JapanLaboratory of Computational Genomics, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, JapanDivision of Clinical Genetics, Kanazawa University Hospital, Ishikawa 920-8640, JapanDepartment of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, JapanDepartment of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, JapanDepartment of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, JapanPheochromocytoma is a rare form of adrenal hypertension. This study aimed to investigate the clinical characteristics and associated genetic mutations in patients with pheochromocytoma and primary aldosteronism. We retrospectively analyzed data from 23 patients with pheochromocytoma diagnosed and treated between 2011 and 2022. Three cases were complicated by primary aldosteronism. Compared to 15 other patients without primary aldosteronism complications, these three patients had a greater suppression of plasma renin activity (0.2 vs. 2.3 ng/mL/h, p < 0.01) and a higher aldosterone-to-renin ratio (p < 0.01). No significant differences were found in blood pressure, serum potassium levels, or plasma aldosterone concentrations between the two groups. In genetic analysis, among the three patients with pheochromocytoma and primary aldosteronism, two had a KCNJ5 (G151R) mutation in the pheochromocytoma tumor tissues. However, no CYP11B2- or CYP11B1-positive cells were detected via immunostaining in the pheochromocytoma tissues of these three patients. To our knowledge, this is the first study to reveal the presence of the KCNJ5 mutation, commonly considered specific to primary aldosteronism, in pheochromocytoma cases clinically complicated by primary aldosteronism. The findings suggest that patients with pheochromocytoma and suppressed plasma renin activity should be assessed for primary aldosteronism.https://www.jstage.jst.go.jp/article/endocrj/72/2/72_EJ24-0150/_html/-char/enkcnj5next-generation sequencingpheochromocytomaprimary aldosteronism
spellingShingle Xurong Mai
Mitsuhiro Kometani
Toshiaki Kato
Ko Aiga
Shigehiro Karashima
Daisuke Aono
Seigo Konishi
Koshiro Nishimoto
Kazuyoshi Hosomichi
Atsushi Watanabe
Yuko Noda
Yoshiyu Takeda
Takashi Yoneda
Clinical comparison and genetic analysis in pheochromocytoma with primary aldosteronism
Endocrine Journal
kcnj5
next-generation sequencing
pheochromocytoma
primary aldosteronism
title Clinical comparison and genetic analysis in pheochromocytoma with primary aldosteronism
title_full Clinical comparison and genetic analysis in pheochromocytoma with primary aldosteronism
title_fullStr Clinical comparison and genetic analysis in pheochromocytoma with primary aldosteronism
title_full_unstemmed Clinical comparison and genetic analysis in pheochromocytoma with primary aldosteronism
title_short Clinical comparison and genetic analysis in pheochromocytoma with primary aldosteronism
title_sort clinical comparison and genetic analysis in pheochromocytoma with primary aldosteronism
topic kcnj5
next-generation sequencing
pheochromocytoma
primary aldosteronism
url https://www.jstage.jst.go.jp/article/endocrj/72/2/72_EJ24-0150/_html/-char/en
work_keys_str_mv AT xurongmai clinicalcomparisonandgeneticanalysisinpheochromocytomawithprimaryaldosteronism
AT mitsuhirokometani clinicalcomparisonandgeneticanalysisinpheochromocytomawithprimaryaldosteronism
AT toshiakikato clinicalcomparisonandgeneticanalysisinpheochromocytomawithprimaryaldosteronism
AT koaiga clinicalcomparisonandgeneticanalysisinpheochromocytomawithprimaryaldosteronism
AT shigehirokarashima clinicalcomparisonandgeneticanalysisinpheochromocytomawithprimaryaldosteronism
AT daisukeaono clinicalcomparisonandgeneticanalysisinpheochromocytomawithprimaryaldosteronism
AT seigokonishi clinicalcomparisonandgeneticanalysisinpheochromocytomawithprimaryaldosteronism
AT koshironishimoto clinicalcomparisonandgeneticanalysisinpheochromocytomawithprimaryaldosteronism
AT kazuyoshihosomichi clinicalcomparisonandgeneticanalysisinpheochromocytomawithprimaryaldosteronism
AT atsushiwatanabe clinicalcomparisonandgeneticanalysisinpheochromocytomawithprimaryaldosteronism
AT yukonoda clinicalcomparisonandgeneticanalysisinpheochromocytomawithprimaryaldosteronism
AT yoshiyutakeda clinicalcomparisonandgeneticanalysisinpheochromocytomawithprimaryaldosteronism
AT takashiyoneda clinicalcomparisonandgeneticanalysisinpheochromocytomawithprimaryaldosteronism